Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H25NO5 |
| Molecular Weight | 335.3948 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C\C=C1/C[C@@H](C)[C@@](C)(O)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@@H]23
InChI
InChIKey=HKODIGSRFALUTA-IKZAEVNJSA-N
InChI=1S/C18H25NO5/c1-4-12-9-11(2)18(3,22)17(21)23-10-13-5-7-19-8-6-14(15(13)19)24-16(12)20/h4-5,11,14-15,22H,6-10H2,1-3H3/b12-4+/t11-,14-,15-,18-/m1/s1
| Molecular Formula | C18H25NO5 |
| Molecular Weight | 335.3948 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
The pyrrolizidine alkaloid senecionine has been shown to produce an increase in cytosolic free Ca2+ concentration in isolated hepatocytes that correlated with an increase in cellular toxicity. Senecionine inhibits the sequestration of Ca2+ in extramitochondrial and mitochondrial compartments possibly by inactivating free sulfhydryl groups and oxidizing pyridine nucleotides respectively. Senecionine showed moderate antitrypanosomal activity with an IC50 value of 41.78 ug/ml.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0004364 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6533413 |
|||
Target ID: CHEMBL612851 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19505372 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis. | 2015-10 |
|
| Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid. | 2014-05-19 |
|
| The gender-dependent difference of liver GSH antioxidant system in mice and its influence on isoline-induced liver injury. | 2011-02-04 |
|
| Glucuronidation, a new metabolic pathway for pyrrolizidine alkaloids. | 2010-03-15 |
|
| Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991-01-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21573843
Pharmacokinetic experiments of intravenous administration
in the jugular-catheterized rat model: An aqueous solution contained senecionine was administered to rats intravenously at dose of 1.5 mg/kg.
Pharmacokinetic experiments of oral administration
in the jugular-catheterized rat model: An
aqueous solution of senecionine was administered orally
to rats by gavage at doses of 24, 12, and 6 mg/kg.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8378933
Senecionine was cocultured for 2 hr with a NADPH-generating system and rat liver S9. Senecionine showed a dose-dependent inhibition of colony formation at 50, 100, and 300 uM and induction of megalocytosis at 500 uM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:52:57 GMT 2025
by
admin
on
Mon Mar 31 19:52:57 GMT 2025
|
| Record UNII |
3179A6U4PN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
480-79-5
Created by
admin on Mon Mar 31 19:52:57 GMT 2025 , Edited by admin on Mon Mar 31 19:52:57 GMT 2025
|
PRIMARY | |||
|
5281733
Created by
admin on Mon Mar 31 19:52:57 GMT 2025 , Edited by admin on Mon Mar 31 19:52:57 GMT 2025
|
PRIMARY | |||
|
DTXSID601016480
Created by
admin on Mon Mar 31 19:52:57 GMT 2025 , Edited by admin on Mon Mar 31 19:52:57 GMT 2025
|
PRIMARY | |||
|
79540
Created by
admin on Mon Mar 31 19:52:57 GMT 2025 , Edited by admin on Mon Mar 31 19:52:57 GMT 2025
|
PRIMARY | |||
|
m9860
Created by
admin on Mon Mar 31 19:52:57 GMT 2025 , Edited by admin on Mon Mar 31 19:52:57 GMT 2025
|
PRIMARY | Merck Index | ||
|
3179A6U4PN
Created by
admin on Mon Mar 31 19:52:57 GMT 2025 , Edited by admin on Mon Mar 31 19:52:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Butterbur root alkaloid.
|